All Stories Page

Why We're MADE FOR THIS

Learn what we're doing to transform health care, prepare the next generation of leaders, and solve the world's greatest medical challenges.

Stories

An Enduring Gift: The Branch Endowment for Duke Heart and Duke Cancer Institute
It's all about leaving a legacy. That’s what Brad Branch said about establishing the Catherine S. and J. Bradford Branch Fund with his wife, Catherine Shingleton Branch. Through a generous estate gift to Duke, the couple has created an endowment to benefit both Duke Heart and Duke Cancer Institute (DCI).
The Road to Recovery
The May family made it through a harrowing injury with help from plenty of Duke friends.
Artificial Intelligence in Health Care: Promise and Pitfalls

Clinicians, researchers, and educators at Duke University School of Medicine and across Duke Health are using artificial intelligence (AI) to schedule surgeries more efficiently, give students immediate feedback on academic writing, and help speed up drug discovery.

Filiano Awarded Grant to Study Key Questions About Deadly Childhood Disease
Anthony Filiano, PhD, an assistant professor in the Duke Department of Neurosurgery, has received a $375,000 grant from the Rosenau Family Research Foundation for a three-year project titled, “Immune Responses in Peripheral Nerves After Hematopoietic Stem Cell Transplants for Krabbe.”
First Presidential Distinguished Chair Named in Honor of Chancellor Washington, Awarded to Dzirasa

School of Medicine Dean Mary E. Klotman, MD, announced this week that Duke’s first Presidential Distinguished Chair will be named in honor of outgoing Chancellor for Health Affairs A. Eugene Washington, MD, and his wife, Marie.

The anonymous donor who established the inaugural Presidential Distinguished Chair in early 2021 said the gift was intended to support superb science and to honor the Washingtons. The professorship will be known as A. Eugene and Marie Washington Presidential Distinguished Chair.

Patient’s Gift Launches Melanoma Survivorship Program
Prior to 2011, the life expectancy of an individual diagnosed with metastatic melanoma was generally measured in months. There were no good treatment options. Among patients diagnosed with stage 4 melanoma, 50% developed metastasis to the brain, and only 5% were still alive five years after diagnosis.